Henry F. Vaughan organizations. Among the breakthroughs in disease control during his deanship, the public health school contributed through the development of the first influenza vaccine by Dr. Thomas Francis Jr. and the polio vaccine by Dr. Jonas Salk in 1954. Vaughan was heavily involved with the construction of the Public Health Building. He was also able to attain Nathan Sinai, Thomas Francis, and Kenneth Easlick as faculties who are highly regarded in the field of public health to establish a real competence in health services organization and epidemiology. By the end of retirement in 1960, Vaughan created a school that is the
SAV001 a feasible option for an HIV vaccine. Indeed, Jonas Salk developed a therapeutic HIV vaccine in 1987, called Remune now being developed by Immune Response BioPharma, Inc., is based on the killed whole virus approach. Remune vaccine has completed over 25 clinical studies to date and showed a robust mechanism of action restoring white blood cell counts in CD4 & CD8 T cells by reducing viral load and increasing immunity. Also, a group of researchers and professionals in the field of HIV strongly advocates that the killed HIV approach must be taken to fight back the global HIV and AIDS